Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederir.ionispharma.com
Ionis Pharmaceuticals, Inc. News Releases
Get the latest updates from Ionis Pharmaceuticals, Inc. News Releases directly as they happen.
Follow now 38 followers
Latest posts
Last updated 8 days ago
Ionis to host 2025 virtual Annual Meeting of Stockholders
8 days ago
CARLSBAD, Calif. --(BUSINESS WIRE)--May 6, 2025-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today...
Ionis reports first quarter 2025 financial results
14 days ago
- Encouraging start to first independent launch with TRYNGOLZA TM - -...
New Harris Poll findings reveal HAE patients are unsatisfied with current prophylactic treatment options, with over 90% interested in trying new therapies
15 days ago
– Despite currently available treatment options, the majority of surveyed adults with...
Ionis to hold first quarter 2025 financial results webcast
28 days ago
Webcast scheduled for Wednesday, April 30 at 11:30 a.m. Eastern Time CARLSBAD...
Ionis to host expert panel discussion on sHTG
about 1 month ago
– Webinar scheduled for Monday, April 14 at 11:00 a.m. ET –...
Ionis to present at upcoming investor conferences
about 1 month ago
CARLSBAD, Calif. --(BUSINESS WIRE)--Mar. 31, 2025-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today...
Ionis expands partnership with Sobi to include olezarsen commercialization outside the U.S.
about 2 months ago
– Agreement enables olezarsen to reach people living with conditions associated with...
Ionis and Ono announce global license agreement for sapablursen in polycythemia vera
2 months ago
CARLSBAD, Calif. & OSAKA, Japan --(BUSINESS WIRE)--Mar. 11, 2025-- Ionis Pharmaceuticals, Inc...
WAINZUA (eplontersen) approved in the EU for the treatment of hereditary transthyretin-mediated amyloidosis in adults with stage 1 or stage 2 polyneuropathy
2 months ago
– Second major approval for WAINZUA, which is marketed in the U.S...
Ionis to present at upcoming investor conferences
3 months ago
CARLSBAD, Calif. --(BUSINESS WIRE)--Feb. 25, 2025-- Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today...
New positive donidalorsen data to be presented at AAAAI/WAO Joint Congress highlight sustained HAE attack rate reduction and disease control
3 months ago
– Data also show significant and clinically meaningful improvements in quality-of-life measures...
Ionis reports fourth quarter and full year 2024 financial results
3 months ago
- First independent launch underway following TRYNGOLZA TM approval - - Second...